Mufg Securities Emea PLC Abiomed Inc Transaction History

Mufg Securities Emea PLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 13, 2019	SELL	$250.96 - $284.94 $31 Million - $35.2 Million	-123,400 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$276.39 - $362.25 $34.1 Million - $44.7 Million	123,400 New	123,400 $35.2 Million
Q4 2018 Feb 14, 2019	SELL	$281.08 - $444.25 $342,074 - $540,652	-1,217 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$354.53 - $449.75 $414,800 - $526,207	1,170 Added 2489.36%	1,217 $547,000
Q2 2018 Aug 01, 2018	BUY	$278.07 - $446.21 $13,069 - $20,971	47 New	47 $19,000

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of Mufg Securities Emea PLC, based on Form 13F filings with the SEC.

Stay updated on Mufg Securities Emea PLC with notifications on news.